1,130
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Negative perceptions of hepatitis B vaccination among attendees of an urban free testing center for sexually transmitted infections in France

, , , &
Pages 998-1004 | Received 03 Aug 2016, Accepted 21 Nov 2016, Published online: 21 Feb 2017

References

  • Denis F, Levy-Bruhl D. Mass vaccination against hepatitis B: the French example. Curr Topics Microbiol Immunol 2006; 304:115-29; PMID:16989267
  • Herroelen L, de Keyser J, Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet 1991; 338(8776):1174-5; PMID:1682594; http://dx.doi.org/10.1016/0140-6736(91)92034-Y
  • Mailand MT, Frederiksen JL. Vaccines and multiple sclerosis: a systematic review. J Neurol 2016; [Epub ahead of print]; PMID:27604618
  • Balinska MA, Leon C. Perceptions of hepatitis B vaccination in France. Analysis of three surveys. Revue d'epidemiologie Et De Sante Publique 2006; 54 Spec No 1:1S95-1S101; PMID:17073136
  • Meffre C, Le Strat Y, Delarocque-Astagneau E, Dubois F, Antona D, Lemasson JM, Warszawski J, Steinmetz J, Coste D, Meyer JF, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Medical Virol 2010; 82(4):546-55; PMID:20166185; http://dx.doi.org/10.1002/jmv.21734
  • Greenwood B. The contribution of vaccination to global health: past, present and future. Philosophical Transactions Royal Soci London Series B, Biol Sci 2014; 369(1645):20130433; PMID:24821919; http://dx.doi.org/10.1098/rstb.2013.0433
  • Levy-Bruhl D. Successes and failures of anti-HBV vaccination in France: historical background and questions for research. Revue d'epidemiologie Et De Sante Publique 2006; 54 Spec No 1:1S89-1S94; PMID:17073135
  • Direction générale de la Santé, Comité technique des vaccinations. Guide des vaccinations. Édition 2012. Saint-Denis: Inpes, 2012. Available at: http://www.inpes.sante.fr/10000/themes/vaccination/guide-vaccination-2012/pdf/GuideVaccinations2012_Opinions_et_comportements_vis_vis_de_la_vaccination.pdf.
  • Tosini W, Rioux C, Pélissier G, Bouvet E. Étude de perception des risques de l'hépatite virale B et de sa prévention vaccinale dans une Consultation de dépistage anonyme et gratuit (CDAG) parisienne en 2007. BEH 2009; 2009(20-21):217-0
  • http://www.inpes.sante.fr/Barometres/BS2005/pdf/BS2005_Vaccination.pdf. 2005
  • Peretti-Watel P, Verger P, Raude J, Constant A, Gautier A, Jestin C, Beck F. Dramatic change in public attitudes toward vaccination during the 2009 influenza A(H1N1) pandemic in France. Euro Surveill 2013; 18(44): 15-22.
  • Sturkenboom MC, Abenhaim L, Wolfson C, Roulet E, Heinzelf O, Gout O. Vaccinations, demyelination, and multiple sclerosis study (VDAMS). Pharmacoepidemiol Drug Safety 1999; 8:S170-1
  • Mikaeloff Y, Caridade G, Rossier M, Suissa S, Tardieu M. Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Archilves Pediatrics Adolescent Med 2007; 161(12):1214-5; ; http://dx.doi.org/10.1001/archpedi.161.12.1214
  • Zipp F, Weil JG, Einhaupl KM. No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 1999; 5(9):964-5; PMID:10470051; http://dx.doi.org/10.1038/12376
  • Sadovnick AD, Scheifele DW. School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet 2000; 355(9203):549-50; PMID:10683009; http://dx.doi.org/10.1016/S0140-6736(99)02991-8
  • Ascherio A, Zhang SM, Hernan MA, Olek MJ, Coplan PM, Brodovicz K. Hepatitis B vaccination and the risk of multiple sclerosis. N Eng J Med 2001; 344(5):327-32; PMID:11172163; http://dx.doi.org/10.1056/NEJM200102013440502
  • Touze E, Fourrier A, Rue-Fenouche C, Ronde-Oustau V, Jeantaud I, Begaud B, Alpérovitch A. Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study. Neuroepidemiology 2002; 21(4):180-6; PMID:12065880; http://dx.doi.org/10.1159/000059520
  • Fourrier A, Touze E, Alperovitch A, Begaud B. Association between hepatitis B vaccine and multiple sclerosis: a case-control study. Pharmacoepidemiol Drug Safety 1999; 8:S140-1
  • DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, Shinefield HR, Mullooly JP, Likosky W, Chen RT. Vaccinations and risk of central nervous system demyelinating diseases in adults. Archives Neurol 2003; 60(4):504-9; PMID:12707063; http://dx.doi.org/10.1001/archneur.60.4.504
  • Mikaeloff Y, Caridade G, Suissa S, Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009; 72(10):873-80; PMID:18843097; http://dx.doi.org/10.1212/01.wnl.0000335762.42177.07
  • Mikaeloff Y, Caridade G, Assi S, Tardieu M, Suissa S, Society KsgotFN. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 2007; 130(Pt 4):1105-10; PMID:17276994
  • Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S, Vaccines in Multiple Sclerosis Study G. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Eng J Med 2001; 344(5):319-26
  • Hernan MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 2004; 63(5):838-42; PMID:15365133; http://dx.doi.org/10.1212/01.WNL.0000138433.61870.82
  • Official Statement of the Agence Française de Sécurité Sanitaire des Produits de santé. February 2012. Bilan de pharmacovigilance et profil de securite d'emploi des vaccins contre l'hepatite B. Available at: http://ansmsantefr/content/download/38801/509771/version/1/file/Bilan-VHBpdf.
  • Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351(9103):637-41; PMID:9500320; http://dx.doi.org/10.1016/S0140-6736(97)11096-0
  • Brown KF, Long SJ, Ramsay M, Hudson MJ, Green J, Vincent CA, Kroll JS, Fraser G, Sevdalis N. U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis. Vaccine 2012; 30(10):1855-64; PMID:22230590; http://dx.doi.org/10.1016/j.vaccine.2011.12.127
  • Larson HJ, Wilson R, Hanley S, Parys A, Paterson P. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation. Hum Vaccines Immunotherapeutics. 2014; 10(9):2543-50; PMID:25483472; http://dx.doi.org/10.4161/21645515.2014.969618
  • Larson HJ, de Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, Cook AR, Jones NS. The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey. Ebiomedecine 2016; 12:295-301
  • Jacobson RM, Targonski PV, Poland GA. A taxonomy of reasoning flaws in the anti-vaccine movement. Vaccine 2007; 25(16):3146-52; PMID:17292515; http://dx.doi.org/10.1016/j.vaccine.2007.01.046
  • Poland GA, Jacobson RM. The age-old struggle against the antivaccinationists. N Eng J Med 2011; 364(2):97-9; PMID:21226573; http://dx.doi.org/10.1056/NEJMp1010594
  • INSEE (Institut National de la Statistique et des Etudes Economiques). http://www.insee.fr/fr/themes/document.asp?reg_id = 0&ref_id = T16F035. 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.